Ameliorating the psoriasis-like erythema, scaling, and thickening and the expression of CK6 and CK17. Decreasing inflammatory cytokines such as IFN-γ, IL-6, and TNF-α. Reducing the number of Th1. Increasing the number of Th2.i90op. The gene discussed is KRT17; the disease is psoriasis.